American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,881 | -1,410 | -1,093 | -779 | -379 |
| Depreciation Amortization | 8 | 51 | 38 | 26 | 13 |
| Accounts receivable | -7 | 242 | 285 | 240 | 186 |
| Accounts payable and accrued liabilities | 24 | 78 | 268 | 203 | 161 |
| Other Working Capital | -138 | 620 | 906 | 675 | 339 |
| Other Operating Activity | -2,131 | -349 | -561 | -447 | -333 |
| Operating Cash Flow | $-363 | $-768 | $-157 | $-82 | $-13 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | 247 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $247 | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 901 | 901 | 673 | 462 |
| Debt Issued | 250 | 955 | 280 | 150 | 0 |
| Debt Repayment | -100 | -90 | -50 | -50 | 0 |
| Other Financing Activity | 0 | -1,079 | -1,079 | -804 | -547 |
| Financing Cash Flow | $150 | $687 | $52 | $-31 | $-85 |
| Beginning Cash Position | 34 | 115 | 115 | 115 | 115 |
| End Cash Position | 68 | 34 | 10 | 2 | 17 |
| Net Cash Flow | $34 | $-81 | $-105 | $-113 | $-98 |
| Free Cash Flow | |||||
| Operating Cash Flow | -363 | -768 | -157 | -82 | -13 |
| Free Cash Flow | -363 | -768 | -157 | -82 | -13 |